• No results found

Roflumilast: first phosphodiesterase 4 inhibitor approved for treatment of COPD

N/A
N/A
Protected

Academic year: 2020

Share "Roflumilast: first phosphodiesterase 4 inhibitor approved for treatment of COPD"

Copied!
12
0
0

Loading.... (view fulltext now)

Full text

Loading

Figure

Figure 1 Structure of roflumilast and its metabolic inactivation.
Table 1 Patient demographics in the large, randomized roflumilast treatment trials
Table 2 Patient outcomes in the roflumilast treatment trials

References

Related documents

In the snail, it would seem reasonable to suggest that sexual females are favored in the coevolution- ary hot spots where parasites are common, and that asexual females are favored

Alveolar epithelial wound repair in vitro was increased after treatment of the wounded A549 alveolar epithelial monolayer with induced pluripotent stem cell conditioned medium

With the help of these automata we are to able to understand how a machine compute and solve problems.[2,3,4,5,6] Mathematical model of such machines can be represented by some

Females of the 1st EG, who had one physical education class for a week and two hours of independent training, showed a certain trend to increase in the BA parameters (from

Repeat bone scan in the UR group showed flare of bone lesions in three patients, progression of bone metastases in one patient, and improvement of bone metastases in one

We explored the potential of a novel CT-emphysema index/ FEV 1 approach to predict COPD-associated mortality and showed in our cohort that “severe mixed airway-emphysema” had

Therefore it makes tremendous sense for a brand to procure a celebrity for its

junction proteins, Cx43 is the most common one in the skin tissue and plays a major role in the process of wound healing, such as dermal fibroblast migration [33]. Cx43 is